Replies to post #529412 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Poor Man -,

You would think a break down in the system would be the result but just like on the street, turf wars determine who is allowed to play and by how much to keep the heat off. Like you basically said, too many players and too much greed serves no one’s best interest if everything collapses. There is always an unwritten code in play. Best wishes.

[JerryCampbell]

Agree with your points on market cap.

Fails-to-deliver are NOT a way to track naked short selling. Consider the SEC's statement "Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, and are not evidence of abusive short selling or “naked” short selling."

source: https://www.sec.gov/data/foiadocsfailsdatahtm

This is one of those cases where something is repeated endlessly, yet still wrong.

[Chiugray]

On what I say, basically I stick to my general sentiment, "I can't tell you for a fact, but I know it's true".

On what you say...
Regarding OTC, I'm pretty sure there is more naked shorting on the OTC than a Nasdaq, by definition of level of regulation on these exchanges. So just because companies generally do not exceed $1B mkt cap, that does not argue against, but is complementary to my point as to why we have a lower stock price: the amount of buying on OTC is insufficient to offset the amount of selling (supplemented by naked shorting). But if there was not naked shorting on OTC, who knows, the price could be higher (and I think so).

Regarding FTD, the issue is naked shorts, not the shorts that are reporting it.

[CrashOverride]

Typically large companies on OTC are foreign represented as an ADR so yes we are doing quite well for a company not traded on an overseas exchange. OTC companies are usually much smaller in market cap than NWBO as we are today. That means a lot of smart money are behind DCVax.

Yet if you consider the market potential of our intellectual property we are certainly undervalued by at least 9 billion at this pre-approval yet proven efficacy stage. Our price remains stagnant because we need more buyers.

OTC acts as a barrier to entry as only the most risk taking investors like Michael Bigger, Steve Derby, and Robert Heffner are willing to front run everyone else to mine this gold before it's revealed to the broader investment community. There's simply a limited number of investors of this caliber willing to risk capital at this stage.

On the flip side thank Linda Powers for delisting to OTC which provided us this one in a lifetime arbitrage opportunity! We have less competition for shares! I don't think we will be here much longer. Buy what you can without threat of divorce. She will thank you later in my personal opinion.